Trial Profile
Phase 1 Dose Ranging Study to Evaluate Safety and Tolerability of Talaporfin Sodium (LS11) Photodynamic Therapy in Subjects With Advanced Age-Related Macular Disease
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2014
Price :
$35
*
At a glance
- Drugs Talaporfin (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Sponsors Light Sciences Corporation
- 23 Apr 2014 New trial record